Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX)

18 filings reported holding QNRX - Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S as of Q1 2025.
Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing one (1) Ordinary Shares, no par value per share QNRX The Nasdaq Stock Market LLC Ordinary S (QNRX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 402K shares of 9.35M outstanding shares and own 4.29% of the company stock.
Largest 10 shareholders include UBS Group AG (219K shares), Apollon Wealth Management, LLC (80K shares), RHUMBLINE ADVISERS (41.7K shares), RAYMOND JAMES FINANCIAL INC (25.1K shares), Lido Advisors, LLC (23.5K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.2K shares), MORGAN STANLEY (456 shares), JPMORGAN CHASE & CO (144 shares), Raiffeisen Bank International AG (17 shares), and TWO SIGMA SECURITIES, LLC (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.